Abiopharma

BioNTech Announces Third Quarter 2025 Financial Results and Corporate Update

Merck Foundation Launches $22 Million Initiative to Improve Cardiovascular Care in the U.S.

Liquidia Corporation Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Henry Schein One and AWS Collaborate to Transform Global Dentistry with Generative AI

IDEXX Laboratories Announces Third Quarter Results

TScan Therapeutics Reaches Agreement with FDA on Pivotal Study Design for TSC-101 and Announces Strategic Prioritization to Advance TSC-101 and Extend Cash Runway into H2 2027

Surmodics Announces PROWL Registry 160-Patient Data to be Presented in Industry-Sponsored Session at VIVA Conference on November 3

Serina Therapeutics Provides Regulatory Update on SER-252 Program

Aurinia Pharmaceuticals to Report Financial Results for the Three and Nine Months Ended September 30, 2025 and Provide Update on Recent Business Progress on November 4, 2025

The Ensign Group Expands in Utah